Executive candidates distinguish themselves through résumés and LinkedIn profiles that blend mastery of emerging technologies with proven leadership excellence.

CryptoQuant CEO Ki Young Ju announced that Bitcoin’s bull cycle had ended and predicted that the price would decline or move ...

Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...

In the past, fielding technologies to warfighters has followed a structured lather, rinse, repeat routine. The demand signal for a capability comes ...

John Johnson has not appeared on Broadway. How many West End shows has John Johnson been in? John Johnson has appeared on London's West End in 1 shows. What was John Johnson's first West End show ...

A recently published study by the the Western Ontario Registry for Early OA (WOREO) Knee Study team suggests that while synovitis increases in OA, the exhaustion and dysfunction of immune-regulatory ...

Anthony Salvanto, Ph.D., is CBS News' executive director of elections and ... YouGov survey interviewed a nationally representative sample of speech watchers immediately following the president's ...

DURHAM, N.C. & SEATTLE--(BUSINESS WIRE)--Leading epigenome company Tune Therapeutics is proud to announce that veteran drug-development executive John McHutchison AO, MD will be its new CEO and ...

Kevin Scott is Microsoft’s chief technology officer. He is an innovative leader driving the technical vision to achieve Microsoft’s mission, and is passionate about creating technologies that benefit ...

Amy is an ACA and the CEO and founder of OnPoint Learning ... in a feasibility study include the following. Below are two examples of feasibility studies. The first involves expansion plans ...

Bluebird bio to be acquired by Carlyle Group & SK Capital, offering up to $9.84/share based on product performance. Former Mirati CEO David Meek set to lead bluebird post-acquisition, with deal ...

Europe's biggest and best health resource In Europe, national biobanks started in the late 1990s and early 2000s. However, they did not come together in a pan-European initiative until a broad ...